Who owns HRTX?
Institutional ownership of Heron Therapeutics Inc. from Form 13F, Q2 2026
162 institutional managers reported holding Heron Therapeutics Inc. (HRTX) in Form 13F filings for Q2 2026, with 133,705,430 shares worth $57.2M. The largest reported holder was Rubric Capital Management LP. Managers that filed both quarters cut a net 23,086,799 shares (-14.7%). 20 opened new positions and 22 sold out.
- Funds holding
- 162
- Value held
- $57.2M
- New / sold out
- 20 / 22
- Net shares, same filers
- -14.7%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of HRTX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Rubric Capital Management LP | $12.8M | 22.5% | 30,046,828 | Unchanged |
| Clearline Capital LP | $4.9M | 8.5% | 11,383,961 | Trimmed |
| BlackRock, Inc. | $4.5M | 7.9% | 10,550,750 | Added |
| Velan Capital Investment Management LP | $3.7M | 6.5% | 8,753,290 | Unchanged |
| Vanguard Capital Management LLC | $3.3M | 5.8% | 7,782,741 | Trimmed |
| Tejara Capital Ltd | $2.8M | 4.9% | 6,510,795 | Added |
| Tang Capital Management LLC | $2.7M | 4.7% | 6,250,000 | Unchanged |
| Geode Capital Management, LLC | $1.8M | 3.2% | 4,270,980 | Added |
| Millennium Management LLC | $1.7M | 3.0% | 4,070,101 | Trimmed |
| JW Asset Management, LLC | $1.6M | 2.8% | 3,751,073 | Unchanged |
| State Street Corp | $1.4M | 2.4% | 3,228,557 | Trimmed |
| UBS Group AG | $1.3M | 2.2% | 2,997,073 | Added |
| Pale Fire Capital SE | $1.1M | 1.9% | 2,511,478 | Trimmed |
| Marshall Wace, LLP | $1.0M | 1.8% | 2,354,193 | New |
| Congress Park Capital LLC | $861K | 1.5% | 2,016,447 | Trimmed |
| Richmond Brothers, Inc. | $765K | 1.3% | 1,792,319 | Added |
| Vanguard Portfolio Management LLC | $675K | 1.2% | 1,580,510 | Added |
| AQR Capital Management LLC | $663K | 1.2% | 1,553,857 | Added |
| Renaissance Technologies LLC | $643K | 1.1% | 1,506,900 | Trimmed |
| Vanguard Fiduciary Trust Co | $583K | 1.0% | 1,365,119 | Added |
| Goldman Sachs Group Inc | $568K | 1.0% | 1,329,754 | Added |
| Panagora Asset Management Inc | $547K | 1.0% | 1,281,796 | Added |
| Northern Trust Corp | $522K | 0.9% | 1,223,480 | Added |
| Charles Schwab Investment Management Inc | $520K | 0.9% | 1,217,463 | Trimmed |
| Gsa Capital Partners LLP | $445K | 0.8% | 1,042,892 | Added |
Share of 13F holdings is each fund's shares as a share of the 133,705,430 HRTX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Marshall Wace, LLP New+$1.0M
- Qube Research & Technologies Ltd Added+$423K
- Gsa Capital Partners LLP Added+$400K
- AQR Capital Management LLC Added+$389K
- UBS Group AG Added+$304K
- Caption Management, LLC Added+$293K
- Diadema Partners LP New+$196K
- BlackRock, Inc. Added+$190K
- Richmond Brothers, Inc. Added+$152K
- Panagora Asset Management Inc Added+$136K
Biggest sellers in Q2 2026
- Orbimed Advisors LLC Sold out-$7.9M
- Palisade Capital Management, LP Sold out-$4.9M
- Millennium Management LLC Trimmed-$1.5M
- D. E. Shaw & Co., Inc. Trimmed-$1.1M
- Congress Park Capital LLC Trimmed-$861K
- New York State Common Retirement Fund Trimmed-$803K
- Monaco Asset Management SAM Sold out-$687K
- Citadel Advisors LLC Sold out-$607K
- Orchard Capital Management, LLC Sold out-$544K
- Stonepine Capital Management, LLC Trimmed-$389K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $5.0M and sold $22.2M; 58 added and 40 trimmed.
Schedule 13D and 13G filings on HRTX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-01-30VANGUARD GROUP INC SCHEDULE 13G filed by Heron Therapeutics Inc.Schedule 13G
- 2025-11-26Clearline Capital LP SCHEDULE 13G filed by Heron Therapeutics Inc.Schedule 13G
Questions about HRTX ownership
- Who owns HRTX stock?
- 162 institutional investment managers reported HRTX positions in their Form 13F filings for Q2 2026, holding 133,705,430 shares worth $57.2M in total. Rubric Capital Management LP reported the largest position.
- Are funds buying or selling HRTX?
- In Q2 2026, 20 managers opened new HRTX positions, 58 added, 40 trimmed and 22 sold out. Managers that filed in both quarters sold a net 23,086,799 shares.
- How current is this HRTX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to HRTX by CUSIP. Options are left out. HRTX news and filings · HRTX insider trades · Top funds